CClinicalTrials.gg
CompletedNCT02396615SATINUpdated Apr 22, 2015

SATIN WP4 Acute Effect on Appetite of Pineapple Juice With Viscofiber and Red Ginseng

An interventional study of SATIN pineapple and SATIN pineapple control in Healthy, sponsored by University of Copenhagen. Completed at 1 site in Denmark. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-22.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The objective of the study is to establish whether a Pineapple juice with Viscofiber and Red ginseng can enhance satiety and reduce appetite and/or accelerate satiation in the short-term.

Read the detailed description

A double-blind, randomised crossover design will be employed with an experimental (active) condition and a control condition at least one week apart. After having successfully completed screening procedures eligible participants will be invited for two separate test days, at least 7 days apart. On the two test days, the products will be provided in a randomized order as part of a fixed breakfast meal, and subjective appetite ratings will be measured every 30 min for the following 8 hours. Satiety and satiation will be measured through administration of test meals in the laboratory supplied with controlled food intake under free-living conditions

02

Conditions studied

  • Healthy

Keywords

  • Ad libitum energy intake
  • Appetite
03

In context

Lead sponsor

University of Copenhagen is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants who have provided written informed consent
  • Healthy men and women
  • Ages between 18 and 55 years
  • BMI between 25.0-31.9 kg/m2
  • Regular breakfast eaters (eating breakfast ≥ 4 times a week)
  • Regular menstrual periods (women only)

Exclusion criteria

Exclusion Criteria:

  • Significant health problems as judged by the investigator
  • Taking any medication or supplements known to affect appetite or body weight within the past month and/or during the study as judged by the investigator
  • Pregnant, planning to become pregnant within the next 4 weeks or breastfeeding (women only)
  • History of anaphylaxis to food
  • Any known food allergies or food intolerance
  • Smoking, smoking cessation within the past 3 months or nicotine use (electronic cigarettes)
  • Self-reporting currently dieting or having lost/gained significant amount of weight (±3 kg) in the previous 3 months
  • Significant changes in physical activity patterns in the past 4 weeks or intention to change during the study as judged by the investigator
  • Significant change in diet in the past 4 weeks or intention to change the diet during the study as judged by the investigator
  • Use of systemic or local treatment likely to interfere with evaluation of the study parameters as judged by the investigator
  • Participants who work in appetite or feeding related areas
  • Participants not able to comply with the study protocol
  • Post-menopausal (women only)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Active

    Satin pineapple. Active juice with fibre and ginseng

    Dietary Supplement: SATIN pineapple

  • Placebo comparator
    Control

    SATIN pineapple control. Control juice - normal juice prpoducts without added active ingredients

    Dietary Supplement: SATIN pineapple control

Interventions

  • Dietary supplementSATIN pineapple

    Active juice with added fibre and ginseng

  • Dietary supplementSATIN pineapple control

    Control products without active ingredients

06

What researchers measure

Primary outcomes

  1. Ad libitum energy intake

    Total ad libitum energy intake during test day 1

    Time frame: Baseline (week 0)

  2. Ad libitum energy intake

    Total ad libitum energy intake during test day 2

    Time frame: Test day 2 (week 1)

Secondary outcomes

  1. VAS score for appetite sensation - hunger

    Perceptions of hunger, assessed using 100 mm VAS scales

    Time frame: Every 30 min during test day 1 and test day 2

  2. Eating behaviour questionnaire - binge eating scale

    Questionnaire by Gormally et al. 1982

    Time frame: Screening

  3. Eating behaviour questionnaire - Control of Eating

    Questionnaire by Hill et al. 1991

    Time frame: screening

  4. Eating behaviour questionnaire - three factor eating questionnaire

    Three Factor Eating Questionnaire by Stunkard and Messick, 1985

    Time frame: screening

  5. Eating behaviour questionnaire- power of food

    Power of food scale by Lowe et al 2009

    Time frame: screening

  6. VAS score for appetite sensation - fullness

    Perceptions of fullness, assessed using 100 mm VAS scales

    Time frame: every 30 min during test day 1 and test day 2

  7. VAS score for appetite sensation - Desire to eat

    Perceptions of Desire to eat, assessed using 100 mm VAS scales

    Time frame: every 30 min during test day 1 and test day 2

  8. VAS score for appetite sensation - prospective consumption

    Perceptions of prospective suncumption, assessed using 100 mm VAS scales

    Time frame: every 30 min during test day 1 and test day 2

07

Study locations

1 site
  • University of Copenhagen
    Copenhagen, Frederiksberg 1958, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02396615
Lead sponsor
University of Copenhagen
Collaborators
University of Leeds, University of Liverpool
Responsible party
Anders Mikael Sjödin, MD, PHD ass professor (Dr, PhD, Associate Professor,, University of Copenhagen) — Principal investigator
First posted
Mar 24, 2015
Start date
Feb 2015
Primary completion
Apr 2015
Completion
Apr 2015
Last update
Apr 22, 2015

Study contacts

Anders Sjödin, Dr
principal investigator · University of Copenhagen

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion